ChartRow logo
ChartRow
Investing Charts
RMD
ResMed Inc.Stock · HealthcareS&P 500 0.1%
$195.30+$3.41 (+1.78%)as of market close, Jul 24, 2026
CompareLLYUNHJNJABBVISRGABT

RMDResMed Inc. stock price, chart and key statistics

Key stats

Price data

Price
$195.30
Change YTD
-20.22%
Next earnings
Aug 6, 2026 · After close
Market cap
28.3B
Enterprise value
27.1B
Shares outstanding
145.1M
52W low
$180.27
52W high
$293.81
From 52W high
-33.53%
From 52W low
+8.34%
52W range
13%
Beta
0.78

Volume

Rel volume
0.84×
30D volume
1.5M
30D $ vol
296.1M

Fundamentals

Sales (ttm)
5.5B
Sales/share
$38.18
EPS (ttm)
$10.43
FCF (ttm)
1.8B
FCF/share
$12.09
Book value/share
$44.75
Net margin
27.44%
ROE
23.41%
ROA
17.30%
Debt / equity
0.06×
Current ratio
3.01

Growth (CAGR, ttm) · 10Y

Sales
+12.06%
Net income
+15.60%
FCF
+14.62%
Shares
+0.33%

Per-share growth (CAGR, ttm) · 10Y

EPS
+15.24%
Sales/share
+11.70%
FCF/share
+14.25%
Book value/share
+14.15%
Dividend/share
+7.04%
Price
+11.47%
Total return
+12.72%

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)
18.6×
Fwd P/E
15.8×
P/S (ttm)
5.1×
P/B (mrq)
4.4×
P/FCF (ttm)
16.1×
EV/EBITDA (fy)
14.4×
EV/Sales (ttm)
4.9×
FCF yield (ttm)
6.19%
Dividend yield (fwd)
1.23%
Dividend/share (fwd)
$2.40
Buyback yield (ttm)
1.85%
Shareholder yield (ttm)
3.05%

Vs own 10Y history

P/E
1st
P/S
7th
P/B
1st
P/FCF
1st

Bar = where today's multiple sits in RMD's own 10-year range:near a decade-low (cheap)near a decade-high (rich).

Performance

1D
+1.78%
1W
-1.85%
1M
-0.61%
3M
-11.03%
YTD
-20.22%
1Y
-28.56%
5Y
-22.86%

Financial statements

Open full RMD financials →

Related Healthcare

1M
TickerThemePrice1M30D $Vol
LLY
Eli Lilly and Company
Pharmaceuticals$1,196+7.05%3.2B
JNJ
Johnson & Johnson
Pharmaceuticals$263+9.30%2.1B
ABBV
AbbVie Inc.
Biopharma$259+10.36%1.9B
UNH
UnitedHealth Group Incorporated Common Stock (DE)
$421+3.66%2.6B
MRK
Merck & Co. Inc.
Pharmaceuticals$131+8.70%1.3B
TMO
Thermo Fisher Scientific Inc.
Life Sciences$568+15.45%1.1B
AMGN
Amgen Inc.
Biotech$376+7.00%969.4M
ABT
Abbott Laboratories
Medical Devices$103+13.95%1.3B

ResMed Inc. (RMD) trades at $195.30 with a live price and an interactive chart covering 31+ years of daily price history, plus key valuation metrics. ChartRow also publishes RMD's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full RMD financial statements →